declares having received honoraria from Novo Nordisk, Eli Lilly, Akebia Therapeutics, Ardelyx, Becton Dickinson, Endologix, FibroGen, GSK, Medtronic, Neovasc, Provention Bio, ReCor, BrainStorm Cell Therapeutics, Alnylam and Intarcia for consulting activities, and research funding to his institution from AbbVie, Esperion, AstraZeneca, CSL Behring, Novartis and Eli Lilly
What kind of cooperation can we accept
BPC-157 is used for supporting recovery by promoting tissue repair processes in experimental settings (tendon healing, muscle recovery, gastrointestinal lining repair)
It reduces pain and its associated symptoms such as mood changes, sleep problems, and tiredness
High doses may cause temporary headaches due to increased NAD+ turnover and mitochondrial activity
10.1053/j.gastro.2022.01.023 [DOI] [PubMed] [Google Scholar] Lamb C